Plasmapheresis in Guillain-Barre syndrome

A. D. Korczyn*, P. Nisipeanu

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The use of plasmapheresis in Guillain-Barre syndrome is reviewed. The clinical data, based on open-label studies, suggest that PP - if instituted early - prevents further deterioration and accelerates the recovery, e.g. the time until the patient becomes ambulatory. The data do not suggest any effect of PP to patients with axonal damage to those with preceding gastroenteritis or Campylobacter jejuni infections has not been tested. The use of PP should be weighed against the potential complications, especially in units inexperienced with this procedure.

Original languageEnglish
Pages (from-to)417-423
Number of pages7
JournalEuropean Journal of Neurology
Issue number5
StatePublished - 1996


  • Guilliain-Barre syndrome
  • Plasmapheresis
  • Prognosis
  • Therapy


Dive into the research topics of 'Plasmapheresis in Guillain-Barre syndrome'. Together they form a unique fingerprint.

Cite this